Primary results from the SAUL study: atezolizumab for locally advanced or metastatic urothelial carcinoma (UC) or non UC
Richard Cathomas,Axel S Merseburger,Yohann Loriot,Nicholas James,Ernest Choy,Daniel Castellano,Fernando Lopez-Rios,Giuseppe L Banna,Ugo De Giorgi,Cristina Masini,Aristotelis Bamias,Xavier Garcia del Muro,Ignacio Duran,Thomas Powles,Marija Gamulin,Friedemann Zengerling,Lajos Geczi,Craig Gedye,Sabine de Ducla,Simon Fear,Cora N Sternberg SWISS MEDICAL WEEKLY(2019)
AI 理解论文
溯源树
样例